The Patent Finder

The Wistar Institute

25 patents currently held · Updated Nov 18, 2026
8 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

8
Ending by 2030
Jan 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 18, 2027
    The maintenance fee for Adenoviral vectors comprising partial deletions of E3 (US 11,702,675) comes due Jan 18, 2027. Unpaid by Jul 19, 2027, it lapses early.
  • 1 fee due Mar 10, 2027
    The maintenance fee for Adenoviral vectors comprising partial deletions of E3 (US 10,407,696) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.
  • 1 fee due Jun 5, 2027
    The maintenance fee for Substituted Chromenones, IRE1 Inhibitors, and Methods of Using Same (US 11,833,137) comes due Jun 5, 2027. Unpaid by Dec 6, 2027, it lapses early.
  • 1 fee due Jul 12, 2027
    The maintenance fee for Screening method and compounds for modulating telomerase activity (US 9,234,230) comes due Jul 12, 2027. Unpaid by Jan 12, 2028, it lapses early.
  • 1 fee due Oct 12, 2027
    The maintenance fee for Compositions and methods for modulating the activity of Epstein-Barr nuclear antigen 1 (US 9,309,212) comes due Oct 12, 2027. Unpaid by Apr 12, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 20, 2026
  • 1 term has ended since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 6,838,236VPR function and activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,234,080Method for identifying a compound that modulates telomerase activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,338,392Microrna Modulators and Method for Identifying and Using the Same
In force
 · High confidence
In forceHigh confidence
US 8,180,580Method for identifying a compound that modulates SIR2 protein activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,374,838Method for identifying a compound that modulates telomerase activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,377,992TRBD-binding effectors and methods for using the same to modulate telomerase activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,234,230Screening method and compounds for modulating telomerase activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,518,940FP-pocket-binding effectors and methods for using the same to modulate telomerase activity
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,309,212Compositions and methods for modulating the activity of Epstein-Barr nuclear antigen 1
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,624,510Adenoviral vectors comprising partial deletions of E3
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 25 patents shown.
Pro members see all 25.
Pro members: see all 25 patents
Also on record, not counted in the 25: 8 patents in force now held by others · 8 lapsed for an unpaid fee · 65 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 4 abandoned · 15 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited